×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Experiment: GLP-1 Agonist Responder Prediction Study — Precision Medicin
experiment
666 words
KG: PD
2026-03-26
kind:experiment
section:experiments
state:published
Contents
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD
Knowledge Graph
Related Hypotheses (19)
Smartphone-Detected Motor Variability Correction
Score: 0.56
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Microbial Inflammasome Priming Prevention
Score: 0.58
PARP1 Inhibition Therapy
Score: 0.58
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
APOE-TREM2 Interaction Modulation
Score: 0.48
Arginine Methylation Enhancement Therapy
Score: 0.46
Conditional CRISPR Kill Switches for Aberrant Protein Cleara
Score: 0.45
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41
Mitochondrial Calcium Buffering Enhancement via MCU Modulati
Score: 0.38
Show 14 more
Related Analyses (4)
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Related Experiments (22)
Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial
clinical · proposed · Score: 0.40
Tirzepatide vs Semaglutide Anti-Atherosclerotic Effects in A
validation · proposed · Score: 0.90
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
Spatial transcriptomic analysis of multistage ESCC developme
exploratory · proposed · Score: 0.85
Functional analysis of EFNB1-EPHB4 interaction in EMT
exploratory · proposed · Score: 0.80
Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr
exploratory · proposed · Score: 0.75
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 17 more
See Also (11)
LRRK2 G2019S Transgenic Mouse Model
model · KG edge: causes
Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with
MCL1 Gene - Myeloid Cell Leukemia 1
gene · KG edge: implicated_in
IDH1 Gene - Isocitrate Dehydrogenase 1
gene · KG edge: implicated_in
eef1a1
gene · KG edge: implicated_in
DOT1L Gene
gene · KG edge: implicated_in
CNTNAP4 Gene
gene · KG edge: associated_with
APOB Gene
gene · KG edge: implicated_in
ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: implicated_in
DNA Damage Repair Deficiency Validation Study in Parkin
experiment · KG edge: implicated_in
GBA1 (Redirect)
redirect · KG edge: causes
Show 6 more
Knowledge Graph (12 edges)
PD
causes
NEURODEGENERATION
PD
causes
DOPAMINERGIC_NEURONS
PD
causes
neurodegeneration
PD
contributes_to
synucleinopathies
PD
associated_with
DEPRESSION
PD
associated_with
T2DM
NEUROINFLAMMATION
contributes_to
PD
NEUROTROPHINS
treats
PD
AGE
associated_with
PD
SNCA
causes
PD